Danshen is the dried root of Salvia miltiorrhiza, used in mainland China for heart and blood vessel conditions. Its best-documented issue in people is an interaction with the blood thinner warfarin.
Also known as: Salvia miltiorrhiza, red sage, Chinese red sage root.
We did not find trials of danshen as a supplement to draw an amount from, so we do not list one.
It is sold in the US as a dietary supplement. Under the 1994 dietary supplement law (DSHEA), FDA does not approve dietary supplements before they are marketed, and the maker, not FDA, is responsible for safety and labeling.
How it affects clotting: a 2001 review describes several ways danshen affects blood clotting, including blocking platelets, and in rats it raised warfarin levels and its effect. Three published cases describe serious over-anticoagulation and bleeding in people on long-term warfarin who also took danshen, and the author concluded danshen should be avoided with warfarin (Chan 2001).
A 2019 Chinese study of patients on warfarin who also took compound Danshen dripping pills, a Chinese product, found no significant change in warfarin dose or INR in most patients and no bleeding (Lv 2019). That product is a different preparation, so it does not settle the question for danshen supplements.
We could not find a single published half-life or time to peak for danshen that applies to a supplement dose, so we do not list one. Plant extracts are mixtures of many compounds, so no single figure would describe them.
How Dose Track handles peptides · Reconstitution calculator · Half-life calculator